EASD 2025 15 - 19 September 2025

Impact of semaglutide on liver-related responses in people with metabolic dysfunction-associated steatohepatitis (MASH) with/without type 2 diabetes (T2D): Post hoc analysis of the ESSENCE trial

Authors :

Elisabeth Bugianesi¹; Teresa Arias-Loste²; Laurent Castera³; Nathalie Marcela Eklöf⁴; Won Kim⁵; Niels Krarup⁴; Bernhard Ludvik⁶; Philip Newsome⁷; Vlad Ratziu⁸; Mary Rinella⁹; Arun Sanyal¹⁰; Anca Trifan¹¹; Thea Vestergaard⁴; Michael Roden¹²; ESSENCE study group

Affiliations

View Details Hide Details

Keywords

Diabetes

Congress short oral presentation

GLP-1 RA

Semaglutide

PHASE 3 (RCT)

Search Science Hub

Are you a healthcare professional?

Impact of semaglutide on liver-related responses in people with metabolic dysfunction-associated steatohepatitis (MASH) with/without type 2 diabetes (T2D): Post hoc analysis of the ESSENCE trial